What Are Sham Procedures in Pain-Relief Injection Studies?
Sham procedures are control interventions designed to mimic the appearance and experience of an actual invasive procedure without delivering the active therapeutic component, serving as a placebo control to isolate the specific treatment effect from non-specific effects like patient expectations, procedural ritual, and natural history.
Key Components of Sham Procedures
In pain-relief injection studies, sham procedures typically involve:
- Needle insertion to superficial tissues (e.g., onto the lamina rather than into the vertebral body, or into subcutaneous tissue rather than the target structure) 1
- Mimicking procedural sounds and sensations (e.g., mixing PMMA cement in the room without injecting it, tapping on bone to simulate the procedure) 1
- Maintaining identical procedural duration and patient positioning to preserve blinding
- Using the same sterile preparation and draping as the active procedure
- Administering local anesthetic to superficial tissues in some protocols, though this remains controversial 1
Why Sham Controls Matter
The 2025 BMJ guideline on chronic spine pain interventions demonstrates the critical importance of sham controls: all interventional treatments supported by moderate or low certainty evidence showed little to no pain relief compared with sham procedures 2. This reveals that much of the perceived benefit from invasive pain procedures derives from non-specific effects rather than the active intervention itself.
Magnitude of Sham Effects
Research shows sham procedures produce substantial improvements:
- Pain improvement effect size of 0.22 overall, with peak effects at 1 month (effect size 0.34) 3
- Subjective outcomes improve more than objective measures: 42.8% vs 27.1% improvement rates for dichotomized outcomes 3
- In pain-related conditions, sham groups achieve 78% of the improvement seen in active treatment groups 4
- For spine pain specifically, the relative contribution of sham treatment accounts for 87% of the total effect across all conditions 5
Clinical Implications
For Chronic Spine Pain
The 2025 BMJ guideline found with moderate certainty evidence 2:
- Epidural injections of local anesthetic (with or without steroids) have little to no effect on pain relief beyond sham for chronic axial spine pain
- Joint-targeted steroid injections have little to no effect beyond sham for chronic axial spine pain
- Epidural injection of local anesthetic with steroids and dorsal root ganglion radiofrequency have little to no effect beyond sham for chronic radicular spine pain
Safety Considerations
Sham procedures are remarkably safe 3:
- Zero deaths reported in sham treatment arms across systematic reviews
- Major complications extremely rare (0.2%, 95% CI 0.0-0.6%)
- Far safer than active invasive procedures, which carry risks of spinal cord injury, infection, and other serious complications 2
Design Controversies
Local Anesthetic in Sham Arms
The LABEL trial attempted to address whether local anesthetic infiltration in sham procedures contributes to pain relief 1. Results showed that INVEST control patients (who received sham with local anesthetic) had significantly greater pain reduction than patients receiving only local anesthetic injection (p=0.04 for pain, p=0.006 for disability at day 3). This suggests local anesthetic infiltration does not account for sham effects—rather, placebo effects and other non-specific factors are responsible 1.
Common Pitfalls to Avoid
Inadequate blinding: Patients and assessors must remain blinded to treatment allocation. Unblinded trials bias toward negative expectations for sham and positive expectations for active treatment 1
Insufficient engagement matching: Sham procedures must be designed to match patient engagement, motivation, and expectations with the active intervention 6
Failure to validate sham controls: Ideally, sham procedures should be validated in earlier studies before use in definitive efficacy trials 6
Poor adverse event reporting: Only about half of randomized trials report adverse events adequately 2
Bottom Line for Clinical Practice
When evaluating evidence for invasive pain procedures, demand sham-controlled trials rather than comparisons to "usual care" or waitlist controls. The substantial placebo response to invasive procedures (accounting for 78-87% of total effect in pain conditions) means that studies without sham controls cannot establish whether active treatments provide benefit beyond theatrical ritual and patient expectations 5, 4. Given the 8.6% risk of prolonged pain, 2.1% risk of altered consciousness, 1.4% risk of dural puncture, and rare but catastrophic complications from actual invasive procedures 2, the burden of proof for demonstrating efficacy beyond sham is high and currently unmet for most chronic spine pain interventions.